Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42,998,448
-
Number of holders
-
180
-
Total 13F shares, excl. options
-
40,740,565
-
Shares change
-
-2,763,217
-
Total reported value, excl. options
-
$1,374,319,414
-
Value change
-
-$218,609,357
-
Put/Call ratio
-
277%
-
Number of buys
-
117
-
Number of sells
-
-79
-
Price
-
$33.73
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q2 2016
239 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q2 2016.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40,740,565 shares
of 42,998,448 outstanding shares and own 95% of the company stock.
Largest 10 shareholders include FMR LLC (5,567,088 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,431,743 shares), VANGUARD GROUP INC (2,587,221 shares), GILDER GAGNON HOWE & CO LLC (2,033,432 shares), BlackRock Fund Advisors (1,591,688 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1,333,868 shares), STATE STREET CORP (1,197,912 shares), Clearbridge Investments, LLC (1,086,050 shares), DARUMA CAPITAL MANAGEMENT LLC (1,076,724 shares), and BlackRock Institutional Trust Company, N.A. (904,221 shares).
This table shows the top 180 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.